Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples